Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Lys-cys-lys-(beta-dap)-ch2co-s-cyclo(hcys-(n-me)phe-tyr-trp-lys-val)
2. Lysyl-cysteinyl-lysyl-(beta-dap) Cyclo(homocysteinyl-(n-methyl)phenylalanyl-tyrosyl-tryptophyl-lysyl-valyl)thiomethyl Ketone
3. P 829
4. P-829
5. P829 Cpd
1. 161982-62-3
2. P829
3. Ndp0h8e844
4. P-829
5. Depreotide [usan]
6. Depreotide [usan:inn]
7. Unii-ndp0h8e844
8. Depreotide [mi]
9. Depreotide [inn]
10. P829 Cpd
11. Depreotide (usan/inn)
12. P 829
13. Depreotide [who-dd]
14. Schembl456503
15. Chembl1908335
16. Chebi:135908
17. Dtxsid301026951
18. Db11628
19. Hy-114133
20. Cs-0069943
21. D03687
22. Q27284812
23. Lys-cys-lys-(beta-dap)-ch2co-s-cyclo(hcys-(n-me)phe-tyr-trp-lys-val)
24. (2s)-6-amino-2-[[(2r)-2-[[(2s)-6-amino-2-[[(2s)-2-amino-3-[[2-[2-[(2s,5s,8s,11r,14s,17s)-14-(4-aminobutyl)-5-benzyl-8-[(4-hydroxyphenyl)methyl]-11-(1h-indol-3-ylmethyl)-4-methyl-3,6,9,12,15,18-hexaoxo-17-propan-2-yl-1,4,7,10,13,16-hexazacyclooctadec-2-yl]ethylsulfanyl]acetyl]amino]propanoyl]amino]hexanoyl]amino]-3-sulfanylpropanoyl]amino]hexanamide
25. Cyclo(l-homocysteinyl-n-methyl-l-phenylalanyl-l-tyrosyl-d-tryptophyl-l-lysyl-l-valyl) (1->1')-sulfide With 3-((mercaptoacetyl)amino)-l-alanyl-l-lysyl-l-cysteinyl-l-lysinamide
26. Cyclo(l-homocysteinyl-n-methyl-l-phenylalanyl-l-tyrosyl-d-tryptophyl-l-lysyl-l-valyl) (1->1')-sulphide With 3-((mercaptoacetyl)amino)-l-alanyl-l-lysyl-l-cysteinyl-l-lysinamide
27. Cyclo(l-homocysteinyl-n-methyl-l-phenylalanyl-l-tyrosyl-d-tryptophyl-l-lysyl-l-valyl) (1-1')-sulfide With 3-((mercaptoacetyl)amino)-l-alanyl-l-lysyl-l-cysteinyl-l-lysinamide
28. Cyclo(l-homocysteinyl-n-methyl-l-phenylalanyl-l-tyrosyl-d-tryptophyl-l-lysyl-l-valyl), (1->1')-sulfide With 3-(2-mercaptoacetamido)-l-alanyl-l-lysyl-l-cysteinyl-l-lysinamide
29. Cyclo(l-homocysteinyl-n-methyl-l-phenylalanyl-l-tyrosyl-d-tryptophyl-l-lysyl-l-valyl), (1->1')-sulphide With 3-(2-mercaptoacetamido)-l-alanyl-l-lysyl-l-cysteinyl-l-lysinamide
30. Cyclo(l-homocysteinyl-n-methyl-l-phenylalanyl-l-tyrosyl-d-tryptophyl-l-lysyl-l-valyl), (1-1')-sulfide With 3-(2-mercaptoacetamido)-l-alanyl-l-lysyl-l-cysteinyl-l-lysinamide
31. Cyclo(l-homocysteinyl-n-methyl-l-phenylalanyl-l-tyrosyl-d-tryptophyl-l-lysyl-l-valyl), (1-1')-thioether With 3-((mercaptoacetyl)amino)-l-alanyl-l-lysyl-l-cysteinyl-l-lysinamide
32. Lysyl-cysteinyl-lysyl-(beta-dap) Cyclo(homocysteinyl-(n-methyl)phenylalanyl-tyrosyl-tryptophyl-lysyl-valyl)thiomethyl Ketone
| Molecular Weight | 1357.7 g/mol |
|---|---|
| Molecular Formula | C65H96N16O12S2 |
| XLogP3 | 0.6 |
| Hydrogen Bond Donor Count | 17 |
| Hydrogen Bond Acceptor Count | 18 |
| Rotatable Bond Count | 34 |
| Exact Mass | 1356.68350491 g/mol |
| Monoisotopic Mass | 1356.68350491 g/mol |
| Topological Polar Surface Area | 492 Ų |
| Heavy Atom Count | 95 |
| Formal Charge | 0 |
| Complexity | 2490 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 10 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
This medicinal product is for diagnostic use only.
For scintigraphic imaging of suspected malignant tumours in the lung after initial detection, in
combination with CT scan or chest X-ray, in patients with solitary pulmonary nodules.
V09IA05
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
69
PharmaCompass offers a list of P 829 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right P 829 manufacturer or P 829 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred P 829 manufacturer or P 829 supplier.
PharmaCompass also assists you with knowing the P 829 API Price utilized in the formulation of products. P 829 API Price is not always fixed or binding as the P 829 Price is obtained through a variety of data sources. The P 829 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A P 829 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of P 829, including repackagers and relabelers. The FDA regulates P 829 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. P 829 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A P 829 supplier is an individual or a company that provides P 829 active pharmaceutical ingredient (API) or P 829 finished formulations upon request. The P 829 suppliers may include P 829 API manufacturers, exporters, distributors and traders.
P 829 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of P 829 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right P 829 GMP manufacturer or P 829 GMP API supplier for your needs.
A P 829 CoA (Certificate of Analysis) is a formal document that attests to P 829's compliance with P 829 specifications and serves as a tool for batch-level quality control.
P 829 CoA mostly includes findings from lab analyses of a specific batch. For each P 829 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
P 829 may be tested according to a variety of international standards, such as European Pharmacopoeia (P 829 EP), P 829 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (P 829 USP).
